EDAP Announces Appointment of David Horn to Board of Directors

Core Viewpoint - EDAP TMS S.A. has appointed David Horn to its Board of Directors, effective February 11, 2026, enhancing the board's expertise in strategic growth and transformation [1][2]. Group 1: Appointment Details - David Horn brings extensive experience in capital markets and the medical device industry, having served as President and CFO of Seer, Inc. since 2023 and previously at Morgan Stanley for over 20 years [3]. - Horn will be a member of the Audit Committee and Nominations Committee, contributing to strategic planning and execution [2][3]. Group 2: Company Leadership and Strategy - The Chairman of the Board, Lance Willsey, expressed confidence in Horn's ability to support EDAP's growth strategy and enhance shareholder value [3]. - Horn emphasized the importance of EDAP's innovation in focal therapy technology and its potential to expand clinical indications [4]. Group 3: Board Changes - Glen French has stepped down from the Board of Directors effective February 10, 2026, with appreciation expressed for his contributions [4][5].